GOLGA2/GM130, cis-Golgi Matrix Protein, is a Novel Target of Anticancer Gene Therapy

Achievement of long-term survival of patients with lung cancer treated with conventional chemotherapy is still difficult for treatment of metastatic and advanced tumors. Despite recent progress in investigational therapies, survival rates are still disappointingly low and novel adjuvant and systemic...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Chang, Seung-Hee, Hong, Seong-Ho, Jiang, Hu-Lin, Minai-Tehrani, Arash, Yu, Kyeong-Nam, Lee, Jae-Ho, Kim, Ji-Eun, Shin, Ji-Young, Kang, Bitna, Park, Sungjin, Han, Kiwon, Chae, Chanhee, Cho, Myung-Haing
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2012
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3498792/
https://ncbi.nlm.nih.gov/pubmed/22735382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.125
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы